InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,554.13
(
1.07%
)
US TECH 100
18,728.00
(
2.08%
)
Dow Jones
40,861.71
(
0.31%
)
Brent Oil
70.83
(
0.43%
)
Bitcoin
58,385.24
(
1.81%
)
Post# of 796
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Silver Taurus

Send PM Follow Ignore
Followers 6
Posts 478
Boards Moderated 0
Alias Born 07/18/2018

Silver Taurus

Re: None

Friday, 07/26/2019 7:59:00 AM

Friday, July 26, 2019 7:59:00 AM

Post# of 796
DD. This drug was approved 9 months ago. It is not an end all cancer drug It is a last chance treatment after competitor's first and second line therapies don't work, hence it is labeled a third-line chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma (SLL) treatment. The most recent PR stating that it for all oncology indications is a downright falsehood and deceptive to potential investors. Also the drug has serious adverse side effects. Copiktra was originally being developed by Infinity Pharmaceuticals and AbbVie. AbbVie walked away from the partnership in 2016 upon seeing the weak Phase II results.


This article says it all. Investors don't be deceived!

https://www.pharmaceutical-technology.com/comment/fda-approvals-copiktras-commercial-prospects/
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent VSTM News
More VSTM News
InvestorsHub NewsWire

North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM

One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM

Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM

Element79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates • ELMGF • Sep 10, 2024 11:00 AM

Nightfood Holdings Inc. Completes Major Step on Uplist Journey by Closing Strategic All-Stock Acquisition of CarryoutSupplies.com • NGTF • Sep 10, 2024 8:15 AM

Element79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd. • ELEM • Sep 9, 2024 9:34 AM

Start posting your company's news
Only $200 per official company press release!